AusPAR: Dupixent

Australian Public Assessment Report

AusPAR

AusPAR: Dupixent [PDF, 1.05 MB]

AusPAR: Dupixent [Word, 1.73 MB]

AusPAR Attachment 1: Product Information for Dupixent [PDF, 1.45 MB]

AusPAR Attachment 1: Product Information for Dupixent [Word, 1.71 MB]

Device/Product Name

Dupixent

Active ingredients

Dupilumab

AusPAR Date

14 March 2023

Published

17 March 2023

Submission Number

PM-2021-01682-1-5

Submission Type

Extension of indications and major variation (new strength)

Decision

Approved